EDGAR Filing Documents for 0001047469-17-001682

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-17-001682

Filing Date

2017-03-16

Accepted

2017-03-16 16:09:08

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2231344z10-k.htm	10-K	1469402
2	EX-23.1	a2231344zex-23_1.htm	EX-23.1	4554
3	EX-31.1	a2231344zex-31_1.htm	EX-31.1	7933
4	EX-31.2	a2231344zex-31_2.htm	EX-31.2	7938
5	EX-32.1	a2231344zex-32_1.htm	EX-32.1	4400
6	EX-32.2	a2231344zex-32_2.htm	EX-32.2	4443
13	G366467.JPG	g366467.jpg	GRAPHIC	72822
14	G373598.JPG	g373598.jpg	GRAPHIC	60198
	Complete submission text file	0001047469-17-001682.txt		7264378

Data Files

Seq	Description	Document	Type	Size
7	EX-101.INS	catb-20161231.xml	EX-101.INS	1701519
8	EX-101.SCH	catb-20161231.xsd	EX-101.SCH	45716
9	EX-101.CAL	catb-20161231_cal.xml	EX-101.CAL	55152
10	EX-101.LAB	catb-20161231_lab.xml	EX-101.LAB	474918
11	EX-101.PRE	catb-20161231_pre.xml	EX-101.PRE	362832
12	EX-101.DEF	catb-20161231_def.xml	EX-101.DEF	192671

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)